Search hospitals > North Dakota > Fargo
Essentia Health Cancer Center-South University Clinic
Claim this profileFargo, North Dakota 58103
Global Leader in Skin Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Cancer
Conducts research for Lymphoma
150 reported clinical trials
2 medical researchers
Summary
Essentia Health Cancer Center-South University Clinic is a medical facility located in Fargo, North Dakota. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Cancer, Lymphoma and other specialties. Essentia Health Cancer Center-South University Clinic is involved with conducting 150 clinical trials across 309 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Bret E. FridayEssentia Health Cancer Center5 years of reported clinical research
Expert in Skin Cancer
Expert in Cancer
118 reported clinical trials
189 drugs studied
Bret EB FridayEssentia Health - Deer River Clinic5 years of reported clinical research
Studies Glioblastoma
Studies Chemoradiotherapy
2 reported clinical trials
1 drug studied
Clinical Trials running at Essentia Health Cancer Center-South University Clinic
Breast Cancer
Lung Cancer
Breast cancer
Skin Cancer
Bladder Cancer
Cancer
Non-Small Cell Lung Cancer
Bladder Carcinoma
Cutaneous Melanoma
Multiple Myeloma
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Pembrolizumab
for Triple-Negative Breast Cancer
The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembrolizumab. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial may help researchers determine if observation will result in the same risk of cancer coming back as pembrolizumab after surgery in triple-negative breast cancer patients who achieve pathologic complete response after preoperative chemotherapy with pembrolizumab.
Recruiting2 awards Phase 319 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Essentia Health Cancer Center-South University Clinic?
Essentia Health Cancer Center-South University Clinic is a medical facility located in Fargo, North Dakota. This center is recognized for care of Skin Cancer, Breast Cancer, Lung Cancer, Cancer, Lymphoma and other specialties. Essentia Health Cancer Center-South University Clinic is involved with conducting 150 clinical trials across 309 conditions. There are 2 research doctors associated with this hospital, such as Bret E. Friday and Bret EB Friday.